NasdaqGS - Delayed Quote USD
Repligen Corporation (RGEN)
At close: October 25 at 4:00 PM EDT
After hours: October 25 at 4:01 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
602,354.00
638,764.00
801,536.00
670,534.00
366,260.00
--
Cost of Revenue
346,475.00
353,922.00
345,830.00
279,280.00
156,634.00
--
Gross Profit
255,879.00
284,842.00
455,706.00
391,254.00
209,626.00
--
Operating Expense
282,035.00
260,835.00
259,765.00
218,140.00
139,803.00
--
Operating Income
-26,156.00
24,007.00
195,941.00
173,114.00
69,823.00
--
Net Non Operating Interest Income Expense
-19,443.00
-10,026.00
-2,977.00
-12,714.00
-12,133.00
--
Other Income Expense
55,775.00
50,151.00
26,176.00
-6,857.00
1,527.00
--
Pretax Income
10,176.00
64,132.00
219,140.00
153,543.00
59,217.00
--
Tax Provision
12,077.00
22,555.00
33,181.00
25,252.00
-709.00
--
Net Income Common Stockholders
-1,901.00
41,577.00
185,959.00
128,291.00
59,926.00
--
Diluted NI Available to Com Stockholders
-1,901.00
41,577.00
185,959.00
128,291.00
59,926.00
--
Basic EPS
-0.03
0.75
3.35
2.33
1.14
--
Diluted EPS
-0.03
0.74
3.24
2.24
1.11
--
Basic Average Shares
55,815.00
55,720.00
55,460.23
55,015.18
52,553.80
--
Diluted Average Shares
56,149.50
56,377.00
57,455.28
57,264.27
53,892.26
--
Total Operating Income as Reported
7,439.00
54,576.00
224,670.00
167,249.00
69,823.00
--
Total Expenses
628,510.00
614,757.00
605,595.00
497,420.00
296,437.00
--
Net Income from Continuing & Discontinued Operation
-1,901.00
41,577.00
185,959.00
128,291.00
59,926.00
--
Normalized Income
-42,987.32
14,342.86
155,643.76
133,044.38
58,655.07
--
Interest Expense
11,279.00
1,951.00
1,162.00
11,278.00
10,768.00
--
Net Interest Income
-19,443.00
-10,026.00
-2,977.00
-12,714.00
-12,133.00
--
EBIT
21,455.00
66,083.00
220,302.00
164,821.00
69,985.00
--
EBITDA
91,951.00
134,168.00
271,287.00
203,268.00
97,052.00
--
Reconciled Cost of Revenue
346,475.00
353,922.00
345,830.00
279,280.00
156,634.00
--
Reconciled Depreciation
70,496.00
68,085.00
50,985.00
38,447.00
27,067.00
--
Net Income from Continuing Operation Net Minority Interest
-1,901.00
41,577.00
185,959.00
128,291.00
59,926.00
--
Total Unusual Items Excluding Goodwill
52,008.00
42,028.00
35,707.00
-5,689.00
1,741.00
--
Total Unusual Items
52,008.00
42,028.00
35,707.00
-5,689.00
1,741.00
--
Normalized EBITDA
39,943.00
92,140.00
235,580.00
208,957.00
95,311.00
--
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
--
Tax Effect of Unusual Items
10,921.68
14,793.86
5,391.76
-935.62
470.07
--
12/31/2019 - 4/29/1986
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVTR Avantor, Inc.
22.43
-3.61%
WST West Pharmaceutical Services, Inc.
307.92
-6.87%
WRBY Warby Parker Inc.
17.12
-0.23%
SRT3.DE Sartorius Aktiengesellschaft
244.60
-2.00%
COO The Cooper Companies, Inc.
107.82
+0.48%
BDX Becton, Dickinson and Company
238.13
-0.21%
ALGN Align Technology, Inc.
219.30
+1.33%
RMD ResMed Inc.
256.07
+7.12%
STAA STAAR Surgical Company
30.39
+0.23%
STVN Stevanato Group S.p.A.
17.27
-5.83%